ALPS Medical Breakthroughs ETF (SBIO): Price and Financial Metrics ETF
SBIO Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $26.17 | 52-week high | $33.82 |
| Prev. close | $26.19 | 52-week low | $26.02 |
| Day low | $26.02 | Volume | 3,402 |
| Day high | $26.19 | Avg. volume | 8,791 |
| 50-day MA | $29.47 | Dividend yield | N/A |
| 200-day MA | $30.36 |
SBIO Stock Price Chart Interactive Chart >
ALPS Medical Breakthroughs ETF (SBIO) ETF Bio
The investment objective of the ALPS Medical Breakthroughs ETF seeks investment results that correspond generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs Index.
SBIO ETF Info
| Issuer | ALPS Holdings |
| Expense Ratio | 0.5% |
| Underlying Index | Poliwogg Medical Breakthroughs Index |
| Asset Class | Portfolio-Multi Asset |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 88.64M |
| Net Asset Value (NAV) | $26.22 |
| Options? | Yes |
| Total Holdings | 106 |
SBIO Top Holdings
| Symbol | Company | % of Total |
| IMVT | Immunovant Inc. | 4.02% |
| PCVX | Vaxcyte Inc. | 3.84% |
| ALKS | Alkermes PLC | 3.74% |
| INSM | Insmed Inc. | 2.91% |
| FOLD | Amicus Therapeutics Inc. | 2.8% |
| CERE | Cerevel Therapeutics Holdings Inc. | 2.76% |
| ACAD | IA Pharmaceuticals Inc. | 2.74% |
| AXSM | Axsome Therapeutics Inc. | 2.65% |
| KRYS | Krystal Biotech Inc. | 2.6% |
| DNLI | Denali Therapeutics Inc. | 2.27% |
SBIO Price Returns
| 1-mo | -13.67% |
| 3-mo | -16.75% |
| 6-mo | -3.24% |
| 1-year | -13.34% |
| 3-year | -35.48% |
| 5-year | -27.83% |
| YTD | -13.86% |
| 2022 | -28.08% |
| 2021 | -17.55% |
| 2020 | 21.17% |
| 2019 | 50.31% |
| 2018 | -11.81% |